Malleability of the SARS-CoV-2 3CL Mpro active site cavity facilitates binding of clinical antivirals
Authors
Keywords
room temperature X-ray crystallography, SARS-CoV-2, 3CL main protease, 3CL M, protease inhibitor, hepatitis C clinical drugs, enzyme kinetics, drug design, repurposing clinical drugs
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More